Walleye Capital
IMNM icon

Walleye Capital’s Immunome IMNM Stock Holding History

Walleye Capital’s Portfolio IMNM Stock Details IMNM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.43M Buy
+111,183
New +$2.47M 0.01% 1321
2025
Q2 		– Sell
-37,114
Closed -$250K – 4739
2025
Q1 		$250K Buy
+37,114
New +$356K ﹤0.01% 3097
2024
Q3 		– Sell
-25,457
Closed -$308K – 5555
2024
Q2 		$308K Buy
+25,457
New +$398K ﹤0.01% 3953

Other funds holding IMNM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
ES
Enavate Sciences Menlo Park, California $352M AUM 220.14% 1-Year Est. Return

Walleye Capital's IMNM Position: Q1 2026 in Review

Walleye Capital opened a new position in Immunome (IMNM) in Q1 2026: 111,183 shares worth $2.43M. The stake represents 0.01% of the portfolio and ranks #1321 among its holdings. This is a return to the name: Walleye Capital previously reported a position in IMNM as recently as Q1 2025.

Walleye Capital first reported a position in IMNM in Q2 2024 and has held it in 3 quarters since. 200 funds tracked by Wall St. Rank hold IMNM as of Q1 2026.

  • Walleye Capital held 111,183 shares of Immunome worth $2.43M as of Q1 2026.
  • Immunome was a new Walleye Capital position in Q1 2026.
  • Immunome made up 0.01% of Walleye Capital's portfolio in Q1 2026, its #1321 holding.
  • Walleye Capital first reported a position in Immunome in Q2 2024 and has held it in 3 quarters since.
  • 200 funds tracked by Wall St. Rank held Immunome as of Q1 2026.

Based on Walleye Capital's 13F filing for Q1 2026, filed 11 May 2026.